Mt. Laurel, New Jersey
United States
66
2026-03-12
The entities that hold a legal rights for patent applications filed by inventor Wang Xiaozhao:
Xiaozhao Wang from Mt. Laurel, US has applied for patents for these inventions. The list has both pending applications and granted patents:
KRAS INHIBITORS
#2 | 2026-02-05KRAS INHIBITORS
#3 | 2025-12-04QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS
#4 | 2025-08-21SPPL2a INHIBITORS
#5 | 2025-06-19BICYCLOOCTANE KRAS INHIBITORS
#6 | 2025-06-12TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
#7 | 2025-05-22KRAS INHIBITORS
#8 | 2024-12-05PYRAZOLOQUINOLINE KRAS INHIBITORS
#9 | 2024-11-28PYRROLIDINE KRAS INHIBITORS
#10 | 2024-11-072-AZABICYCLO[2.2.1]HEPTANE KRAS INHIBITORS
#11 | 2024-11-07QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS
#12 | 2024-10-31CYCLIC UREA KRAS INHIBITORS
#13 | 2024-10-17VINYL IMIDAZOLE COMPOUNDS AS INHIBITORS OF KRAS
#14 | 2024-03-28FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12V MUTANTS
#15 | 2023-06-22SPIRO COMPOUNDS AS INHIBITORS OF KRAS
#16 | 2023-06-08NAPHTHYRIDINE COMPOUNDS AS INHIBITORS OF KRAS
#17 | 2023-05-18Hetero-tricyclic compounds as inhibitors of KRAS
#18 | 2023-05-11Quinoline compounds as inhibitors of KRAS
#19 | 2023-05-11Pyrazoloquinoline KRAS inhibitors
#20 | 2023-04-20TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
#21 | 2023-04-13TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
#22 | 2023-02-23TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
#23 | 2023-02-02Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
#24 | 2022-12-08HETERO-BICYCLIC INHIBITORS OF KRAS
#25 | 2022-09-29Imidazole and triazole KRAS inhibitors
#26 | 2022-07-28COMBINATION THERAPY COMPRISING A2A/A2B INHIBITORS, PD-1/PD-L1 INHIBITORS, AND ANTI-CD73 ANTIBODIES
#27 | 2022-07-07PYRROLE TRICYCLIC COMPOUNDS AS A2A / A2B INHIBITORS
#28 | 2022-05-05Fused pyrazine derivatives as A2A / A2B inhibitors
#29 | 2022-04-07Bicyclic dione compounds as inhibitors of KRAS
#30 | 2022-03-03Vinyl imidazole compounds as inhibitors of KRAS
#31 | 2021-11-18Fused pyrimidine compounds as KRAS inhibitors
#32 | 2021-11-18FUSED TRICYCLIC KRAS INHIBITORS
#33 | 2021-09-02TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
#34 | 2021-08-26Fused pyrimidine derivatives as A2A/A2B inhibitors
#35 | 2021-07-29CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy
#36 | 2021-07-29Spiro compounds as inhibitors of KRAS
#37 | 2021-07-08Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
#38 | 2021-05-20Pyrrolotriazine compounds as TAM inhibitors
#39 | 2021-05-13Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
#40 | 2021-03-04TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
#41 | 2021-02-04Cyclopropylamines as LSD1 inhibitors
#42 | 2020-10-01Bicyclic heterocycles as FGFR4 inhibitors
#43 | 2020-08-27Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
#44 | 2020-06-11Pyrrolopyrimidine derivatives as TAM inhibitors
#45 | 2020-04-30Pyrrolotriazine compounds as TAM inhibitors
#46 | 2020-01-30Fused pyrazine derivatives as A2A / A2B inhibitors
#47 | 2020-01-23Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors
#48 | 2019-12-12Fused pyrimidine derivatives as A2A / A2B inhibitors
#49 | 2019-11-07Pyrrole tricyclic compounds as A2A / A2B inhibitors
#50 | 2019-09-26IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
#51 | 2019-09-05Bicyclic heterocycles as FGFR4 inhibitors
#52 | 2019-07-11Cyclopropylamines as LSD1 inhibitors
#53 | 2019-05-23TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS
#54 | 2019-04-25TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES AS LSD1 INHIBITORS
#55 | 2019-04-11Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
#56 | 2019-01-31Pyrrolopyrimidine derivatives as TAM inhibitors
#57 | 2018-11-15Pyrrolotriazine compounds as TAM inhibitors
#58 | 2017-12-28Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
#59 | 2017-12-28Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors
#60 | 2017-12-21Triazolopyridines and triazolopyrazines as LSD1 inhibitors
#61 | 2017-11-30Cyclopropylamines as LSD1 inhibitors
#62 | 2017-10-12Bicyclic heterocycles as FGFR4 inhibitors
#63 | 2017-09-28Pyrrolotriazine compounds as tam inhibitors
#64 | 2017-04-27Cyclopropylamines as LSD1 inhibitors
#65 | 2017-03-02Pyrrolopyrimidine derivatives as TAM inhibitors
#66 | 2016-08-25Bicyclic heterocycles as FGFR4 inhibitors
1630657 ⎘